The association between metabolic syndrome and infarct size in patients with acute myocardial infarction

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 4, 2010, Pages 287-293

  Bøhmer, Ellen ^a,b   Seljeflot, Ingebjørg ^a,c   Arnesen, Harald ^a   Hoffmann, Pavel ^a   Abdelnoor, Michael ^a   Halvorsen, Sigrun ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b INNLANDET HOSPITAL TRUST   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Biological markers; Inflammation; Magnetic resonance imaging; Metabolic syndrome X; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; GADOLINIUM; INTERLEUKIN 18; PLASMINOGEN ACTIVATOR INHIBITOR 1; STATIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADIPONECTIN; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERLEUKIN-18; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX;

EID: 77953827344     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.481819     Document Type: Article

References (31)

1. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716
2. Ninomiya JK, L' I talien G, Criqui MH, Whyte JL, Garnst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National health and Nutrition Examination Survey. Circulation 2004; 109:42-46
3. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607
4. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) fi nal report. Circulation 2002;106: 3143-3421
5. Girman CJ, Rhodes T, Mercuri M, Pvö r äl ä K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfi eld M. 4S Group and the AFCAPS/TexCAPS Research Group. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/ Texas Coronary Atherosclerosis Prevention Study (AFCAPS/ TexCAPS). Am J Cardiol 2004;93:136-141
6. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689
7. Malik S, Wong ND, Franklin SS, Kamath TV, L 'I talien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110: 1245-1250
8. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death. J Am Coll Cardiol 2007;49:403-414
9. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K Miyazaki S. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction. Potential association with C-reactive protein. Circ J 2008;72:415-419
10. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Magnifi cat, L ' Hullier I, Beer J-C, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Verg è s B, Cottin Y. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005;165:1192-1198
11. Birhan Yilmaz M, Guray U. Guray Y, Altay H, Demirkan B, Caldir V, Cay S, Refi ker ME, Sasmaz H, Korkmaz S. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Coronary Artery Disease 2005; 16:287-292
12. Burns RJ, Gibbons RJ, Yi Q, Roberts RS, Miller TD, Schaer GL, Anderson JL, Yusuf S; CORE Study Investigators. The relationship of left ventricular ejection fraction, endsystolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39: 30-36
13. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99m Tc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-341
14. Yilmaz MB, Caldir V, Guray Y, Guray U, Altay H, Demirkan B, Cay S, Kisacik HL, Korkmaz S. Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome. Am J Cardiol 2006;97:636-639
15. Gonon AT, Widegren U, Bulhak A, Salehzadeh F, Persson J, Sj ö quist PO, Pernow J. Adiponectin protects against myocardial ischemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide. Cardiovasc Res 2008; 78:116-122
16. Thim T, Bentzon JF, Kristiansen SB, Simonsen U, Andersen HL, Wassermann K, Falk E. Size of myocardial infarction induced by ischemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci 2006;110:665-671
17. Solskov L, Lø f gren B, Pold R, Kristiansen SB, Nielsen TT, Overstreet DH, Schmitz O, B ø tker HE, Lund S, Wegener G. Evaluation of the relationship between hyperinsulinaemia and myocardial ischemia/reperfusion injury in rat model of depression. Clin Sci 2010;118:259-267
18. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006;7:7-11.
19. Palomo I, Alarcó n M, Moore-Carrasco R, Argilé s JM. Hemostasis alterations in metabolic syndrome. Int J Mol 2006;18:969-974
20. Hajer GR, Van Haeften TW, Visseren FLJ, Adipose tissue dysfunction in obesity, diabetes and vascular diseases. Eur Heart J 2008;29:2959-2971
21. Troseid M, Seljefl ot I, Hjerkinn EM, Arnesen H. Interleukin- 18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome. Synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009; 32:486-492
22. Bohmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Effi cacy and safety of immediate angioplasty versus ischemia guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances. J Am Coll Cardiol 2010;55:102-110
23. Sadowski EA, Bennett LK, Chan MR, Wentland AL, GarretAL, Garret RW, Djamali A. Nephrogenic systemic fi brosis: risk factors and incidence estimation. Radiology 2007;243:148-157
24. Hoffmann P, Halvorsen S, Stensæ t h K-H, Brekke M, M ül ler C, Anker GO, Abdelnoor M, Kl ø v NE. Myocardial perfusion in ST-elevation myocardial infarction treated successfully with primary angioplasty. Scand Cardiovasc J 2006; 40:96-104.
25. Kirkwood BR, Sterne JAC. Essentials of medical statistics science, 2nd edn, Massachusetts, USA: Blackwell Science Ltd, 2003.
26. Thanavaro S, Kleiger RE, Province MA, Hubert JW, Miler JP, Krone RJ, Oliver GC. Effect of infarct location on the inhospital prognosis of patients with fi rst transmural myocardial infarction. Circulation 1982;66:742 .
27. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992;86:81-90.
28. Timmer JR, van der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, de Boer MJ, Suryapranata H, Zijlstra F, Zwolle Myocardial Infarction Study Group. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004;148:399-404.
29. Alberti KG, Zimmel P, Shaw J. The metabolic syndrome - a new worldwide defi nition. Lancet 2005;366:1059-1062 (Pubitemid 41338752)
30. Feinberg MS, Schwartz R, Tanne D, Fisman EZ, Hod H, Zagher D, Schwammethal E, Eldar M, Behar S, Tenenbaum A. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol 2007; 99:667-672
31. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS, INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005: 366:1640-1649